When activated Braf (or Nras) in mouse melanocytes is combined with complete loss of function mutations of tumor suppressor genes (Pten, p53, Ink4a, Cdkn2a), melanomas arise rapidly7–9. The gene discussed is CDKN2A; the disease is melanoma.